A one-time-only drug to treat spinal muscular atrophy (SMA) that will cost NT$49 million (US$1.58 million) will soon be covered for infants six months old and under by Taiwan's universal health insurance system.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan conducts M1A2T tank live-fire drill
07/10/2025 11:59 AM - Politics
U.S. introduces bill to combat China's sabotage of Taiwan's underseas cables
07/10/2025 11:13 AM - Society
Taiwan headline news
07/10/2025 10:38 AM - Business
U.S. dollar up in Taipei trading
07/10/2025 10:29 AM - Society
Rain likely to continue across Taiwan on Thursday
07/10/2025 10:06 AM